Investor FAQs

10x Genomics, Inc.’s principal executive offices are located at 6230 Stoneridge Mall Road, Pleasanton, California 94588, and our telephone number is (925) 401-7300.

back to top

10x was incorporated in Delaware on July 2, 2012 under the name Avante Biosystems, Inc. We changed our name to 10X Technologies, Inc. in September 2012 and to 10x Genomics, Inc. in November 2014.

back to top

The 10x Genomics, Inc. ticker is TXG. Shares of our Class A common stock are traded on the Nasdaq exchange.

back to top

Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Reports portion of our Investor Relations website or directly from the SEC at www.sec.gov.

back to top

10x Genomics, Inc.’s fiscal year end is December 31.

back to top

10x Genomics, Inc. does not expect to declare or pay any cash or other dividends on our common stock, as we intend to reinvest cash flow generated by operations in our business.

back to top

10x Genomics, Inc.’s independent registered public accountants are Ernst & Young LLP.

back to top

10x Genomics, Inc. uses American Stock Transfer & Trust Company (“AST”) as our transfer agent. AST’s address is 6201 15th Avenue, Brooklyn, New York 11219. AST’s telephone number is (718) 921-8300 or (800) 937-5449. The American Stock Transfer & Trust Company Call Center is open Monday through Friday, 8AM to 8PM ET. AST can be reached by mail at 6201 15th Avenue, Brooklyn, NY 11219. AST’s website is www.astfinancial.com.

back to top

You can view our Board of Directors by visiting the Board of Directors section of our website.

back to top

You can view our management team by visiting the Executive Team section of our website.

back to top

10x Genomics, Inc. will issue a national press release that includes the date of our quarterly earnings call. When the release is issued, it will be posted on the Events & Presentations section of our website along with the details for a conference and/or webcast to discuss the results.

back to top

You can contact 10x Genomics, Inc.’s Investor Relations via email at investors@10xGenomics.com.

back to top

If your shares are held in street name (by your broker), you must contact the securities firm holding your stock. If you hold stock certificates in your name, questions can be directed to our transfer agent. 10x Genomics, Inc. uses American Stock Transfer & Trust Company (“AST”) as our transfer agent. AST’s address is 6201 15th Avenue, Brooklyn, New York 11219. AST’s telephone number is (718) 921-8300 or (800) 937-5449. The American Stock Transfer & Trust Company Call Center is open Monday through Friday, 8AM to 8PM ET. AST can be reached by mail at 6201 15th Avenue, Brooklyn, NY 11219. AST’s website is www.astfinancial.com.

back to top

If you hold stock certificates in your name, please contact our transfer agent regarding the replacement of lost certificates. 10x Genomics, Inc. uses American Stock Transfer & Trust Company (“AST”) as our transfer agent. AST’s address is 6201 15th Avenue, Brooklyn, New York 11219. AST’s telephone number is (718) 921-8300 or (800) 937-5449. The American Stock Transfer & Trust Company Call Center is open Monday through Friday, 8AM to 8PM ET. AST can be reached by mail at 6201 15th Avenue, Brooklyn, NY 11219. AST’s website is www.astfinancial.com.

back to top

Investor Kit

Download item year list

Subscribe To Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to 10x Genomics to send you the requested Investor Email Alert updates.

* Required

Investor Alert Options

For further information on how we protect your information, please refer to our Privacy Policy.

Unsubscribe

To opt-out of investor email alerts, please enter your email address in the field below and you will be removed from all investor relations email alerts to which you are subscribed. After submitting your email, you will receive a confirmation email to the requested email address. You must click the confirmation link in order to complete your request to unsubscribe. You can elect to receive investor alerts at any time you would like.

* Required

Investor Contacts